Leonardo CEO urges “speed as important as money” as joint ventures progress picks up
The Lynx KF41 can be configured for various roles including IFV, C2 and armoured reconnaissance. (Photo: Rheinmetall)
Leonardo’s Q1 2025 results showed a strong start to the year, with progress being made on two of its joint ventures, and a boost in 20% on new orders compared to March 2024.
The results, presented just over a month and a half after its full year financial results, demonstrated growth spread across all business divisions with the aerostructures seeing a boost, Leonardo CEO Roberto Cingolani disclosed.
Of note were the increase in international export orders, which Cingolani said showed the company was “capturing real international opportunities”, with a 5% increase in orders from the rest of the world from 62%
Already have an account? Log in
Want to keep reading this article?
More from Defence Notes
-
Drones, C-UAS and air base investments top the list in $42 billion US-Qatar defence deal
General Atomics Aeronautical Systems secured a nearly $2 billion deal for MQ-9B uncrewed aerial systems, while Raytheon’s counter-UAS system was secured for $1 billion.
-
Brazilian Congress to review constitution amendment to secure defence budget increase
An amendment to the Brazilian Constitution currently under discussion would permanently assign 2% of annual GDP to the defence budget, potentially cementing modernisation programmes for the country’s armed forces.
-
Rheinmetall vehicle sales almost double as European companies see continued growth
Results for Q1 2025 have been strong across the board for many defence companies in Europe with forward-looking statements and predictions for the full year also looking good.
-
Why is the defence market “exploding exponentially” for autonomous targeting capabilities?
Solutions that identify, engage and destroy targets with minimal or no human intervention are becoming critical on tomorrow’s battlefield.
-
Companies post mostly rosy results but warn of potential dark clouds
First quarter 2025 results have been dropping for companies in the past week but many of the US results come with a health warning in their forward-looking aspects about the potential impact of actions by the Trump administration.